KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Non-cash Items: 2010-2018

  • Teva Pharmaceutical Industries' Non-cash Items fell 87.45% to $2.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $2.4 million, marking a year-over-year decrease of 87.45%. This contributed to the annual value of $2.4 million for FY2018, which is 87.45% down from last year.
  • As of Q4 2018, Teva Pharmaceutical Industries' Non-cash Items stood at $2.4 million, which was down 87.45% from $19.1 million recorded in Q4 2017.
  • In the past 5 years, Teva Pharmaceutical Industries' Non-cash Items ranged from a high of $402.4 million in Q4 2015 and a low of $2.4 million during Q4 2018.
  • For the 2-year period, Teva Pharmaceutical Industries' Non-cash Items averaged around $10.8 million, with its median value being $10.8 million (2017).
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 3,483.02% in 2014, then tumbled by 87.45% in 2018.
  • Teva Pharmaceutical Industries' Non-cash Items (Quarterly) stood at $312.2 million in 2014, then climbed by 28.89% to $402.4 million in 2015, then reached $19.1 million in 2017, then slumped by 87.45% to $2.4 million in 2018.
  • Its Non-cash Items stands at $2.4 million for Q4 2018, versus $19.1 million for Q4 2017 and $402.4 million for Q4 2015.